Skip to main content

AquaBounty Technologies, Inc.

corporate_fare Company Profile

AquaBounty Technologies, Inc.

AQB·NASDAQ·Industrial Applications And Services·CIK 0001603978

AquaBounty has historically focused on producing genetically engineered Atlantic salmon using large-scale recirculating aquaculture system (RAS) farms. The company began constructing a 10,000 metric ton farm in Pioneer, Ohio, but paused construction in June 2023 due to substantial cost increases from inflation and other factors, which also hindered municipal bond financing. To address funding and strategic alternatives, AquaBounty engaged an investment bank. This led to the sale of its grow-out farm in Indiana in July 2024, recurring sales of selected equipment originally intended for the Ohio Farm Project throughout 2024 and 2025, and the sale of its Canadian subsidiary, including broodstock farms in Prince Edward Island, Canada, and its intellectual property for the GE Atlantic salmon, trademarks, and patents in March 2025. Following these transactions, AquaBounty's primary remaining asset is its investment in the Ohio Farm Project, comprising remaining Ohio Equipment Assets and the Ohio Farm Site (land and construction in process). The company continues to work with an investment bank to determine the optimal path for this asset, including its potential sale. AquaBounty has also received a non-binding Letter of Interest to purchase its Ohio subsidiary.

AquaBounty Technologies, Inc. (NASDAQ:AQB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for AQB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • AquaBounty Faces Substantial Going Concern Doubt, Liquidates Core Assets, and Risks Nasdaq Delisting Amidst Dire Financials
  • AquaBounty Technologies Announces $1.15M Registered Direct Offering with Pre-Funded Warrants
  • AquaBounty Finalizes $1.15 Million Dilutive Offering of Common Stock and Warrants

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$18.49M
Diluted EPS
-$4.77
Op. Cash Flow
-$8.74M
Operating Income
-$4.02M
Cash & Equivalents
$501.3K
Total Debt
$3.49M
Debt / Equity
-1.84×
Shares Outstanding
3.88M sh
Source: 10-K · filed 2026-03-31 · accession 0001603978-26-000029
$0.9077 +3.85% today
52-week range · as of 2026-11-17 $0.7742 – $1.64
Market cap
$11.62M
Volume
258.2K (1.5× avg)
3-mo avg 175.1K
Live data · 2026-11-22 12:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AQB - Filings & News (Page 2)

AQB
Mar 31, 2026, 8:05 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.8824
Real-time Price: $0.907674 info
Change: +$0.025274 (+3%) info
Market Cap: $11.617M info
AQB
Feb 12, 2026, 7:09 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.870
Real-time Price: $0.907674 info
Change: +$0.037674 (+4%) info
Market Cap: $11.617M info
AQB
Feb 12, 2026, 7:01 AM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.8976
Real-time Price: $0.907674 info
Change: +$0.010074 (+1%) info
Market Cap: $11.617M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets